Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group-Reference-Cited by-同舟云学术

Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group

Published:2018-04-06 Issue:10 Volume:53 Page:1142-1150
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Tsuji Keiji^ORCID,Kurosaki Masayuki,Itakura Jun,Mori Nami,Takaki Shintaro,Hasebe Chitomi,Akahane Takehiro,Joko Kouji,Yagisawa Hitoshi,Takezawa Jirou,Nakata Ryou,Kusakabe Atsunori,Kojima Yuji,Kimura Hiroyuki,Tamada Takashi,Kobashi Haruhiko,Mitsuda Akeri,Kondou Masahiko,Ogawa Chikara,Uchida Yasushi,Sohda Tetsuro,Narita Ryouichi,Izumi Namiki

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/article/10.1007/s00535-018-1455-1/fulltext.html

Reference32 articles.

1. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1990;12:671–5.

2. Niederau C, Lange S, Heintges T, et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology. 1998;28:1687–95.

3. European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2016. J Hepatol. 2017;66:153–94.

4. American Association for the Study of Liver Diseases, Infectious Diseases Society of America. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org . Accessed 16 Sept 2016.

5. The Japan Society for Hepatology. JSH guidelines for management of hepatitis C virus infection (ver. 5.2). 2016. http://www.jsh.or.jp/medical/guidelines/jsh_guidlines/hepatitis_c . Accessed 15 Dec 2016.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ledipasvir/Sofosbuvir is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir;Internal Medicine;2023

2. A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus‐related decompensated cirrhosis;Hepatology Research;2022-09-20

3. Epidemiology and management of hepatitis B and C in primary care in the Netherlands: data from the Rijnmond Primary Care database;Family Practice;2022-07-23

4. Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis;Journal of Viral Hepatitis;2022-04-06

5. The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy;PLOS ONE;2022-02-23